Cargando…
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
S100 calcium binding protein A16 (S100A16) is expressed in various cancers; however, there are few reports on S100A16 in bladder cancer (BC). We retrospectively investigated clinical data including clinicopathological features in 121 patients with BC who underwent radical cystectomy (RC). Immunohist...
Autores principales: | Katsumata, Hiroki, Matsumoto, Kazumasa, Yanagita, Kengo, Shimizu, Yuriko, Hirano, Shuhei, Kitajima, Kazuki, Koguchi, Dai, Ikeda, Masaomi, Sato, Yuichi, Iwamura, Masatsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572706/ https://www.ncbi.nlm.nih.gov/pubmed/37833982 http://dx.doi.org/10.3390/ijms241914536 |
Ejemplares similares
-
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021) -
Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review
por: Koguchi, Dai, et al.
Publicado: (2022) -
Gemcitabine–Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
por: Koguchi, Dai, et al.
Publicado: (2022) -
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
por: Shimura, Soichiro, et al.
Publicado: (2021) -
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
por: Mori, Kohei, et al.
Publicado: (2022)